# Aulos Bioscience

Source: https://onco.cc/companies/aulos-bioscience/  
OnCo record `aulos-bioscience` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Aulos Bioscience is a Californian biotech whose antibody AU-007 binds interleukin-2 so that the body's own cytokine expands cancer-killing cells without feeding the regulatory cells that dampen immunity.

## Summary

Aulos Bioscience was founded by Apple Tree Partners and Biolojic Design around a computationally designed antibody, AU-007, that binds interleukin-2 at the CD25 epitope. This redirects endogenous and administered IL-2 towards CD8 T cells and natural killer cells and away from regulatory T cells. AU-007 is in phase 1/2 trials alone and with low-dose aldesleukin in solid tumours.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Tags: drug-maker
- HQ: Larkspur, California
- Type: biotech
- Website: https://www.aulosbio.com/

## Sources

- Official website: https://www.aulosbio.com/

## Connected records

- drugs: [AU-007](https://onco.cc/drugs/au-007/)

---
JSON: https://onco.cc/api/v1/entities/aulos-bioscience.json